Searchable abstracts of presentations at key conferences in endocrinology

ea0090p804 | Late-Breaking | ECE2023

Insulin Pump Therapy in Pregnant Women with type 1 Diabetes: Flash Glucose Monitoring vs Sensor Augmented Pump

Mariaca Riveros Karla , Milad Camila , Roca Daria , Amor Antonio , Gimenez Marga , Bellart Jordi , Vinagre Irene

Objectives: Pregnant women with type 1 diabetes (T1D) are associated with an increased risk of maternal fetal complications. Continuous subcutaneous insulin infusion [CSII] has been shown to improve metabolic control and perinatal morbidity. Few studies have compared the use of CSII with SAP (sensor augmented pump) therapy to flash glucose monitoring (FSL) in pregnant women with T1D. We aim to evaluate the possible differences between both monitoring systems associated with CS...

ea0090p450 | Reproductive and Developmental Endocrinology | ECE2023

Cardiovascular Events and Gender-Affirming Hormone Therapy, 10 Years of Follow-Up

Mariaca Riveros Karla , Martinez Veronica , Claro Maria , Sola Clara , Aranda Gloria , Alexandra Hanzu Felicia , Ortega Emilio , Orois Aida , Gomez Esther , Godas Teresa , Mateu Salat Manel , Halperin Irene , Mora Mireia

Objectives: Most transgender persons (0.3-0.5% of total population) are under gender-affirming hormone therapy (GAHT). Several studies have reported an increased morbimortality due to cardiovascular events (CVE), infectious disease and suicide. However, these studies were made on small populations and short follow up. We evaluated the changes on anthropometric variables, risk factors for cardiovascular diseases (CVD) and CVE at 5 and 10 years of follow up in a transgender popu...